A team from Stanford Medicine found with the help of an algorithm a natural peptide, the BRP, which in mice and pigs reduces appetite, and in mice body fat, without the digestive side effects typical of semaglutide (the active substance of Ozempic and Wegovy). The study was published in Nature in 2025. What should be clear from the beginning: it has not yet been tested in people, and between a good result in animals and a drug there are many yea…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
A team from Stanford Medicine found with the help of an algorithm a natural peptide, the BRP, which in mice and pigs reduces appetite, and in mice body fat, without the digestive side effects typical of semaglutide (the active substance of Ozempic and Wegovy). The study was published in Nature in 2025. What should be clear from the beginning: it has not yet been tested in people, and between a good result in animals and a drug there are many yea…